Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Frontage Holdings Corp. ( (HK:1521) ) has shared an update.
Frontage Holdings Corporation has announced a revision of its annual caps related to its Renewed Services Framework Agreement with Hangzhou Tigermed due to increased demand. The revised caps will allow for higher revenue and fees from services provided and received, respectively, over the next three years. These transactions are classified as continuing connected transactions under Hong Kong’s Listing Rules, necessitating reporting and annual review, but exempt from circular and independent shareholders’ approval requirements.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
More about Frontage Holdings Corp.
Frontage Holdings Corporation is a company incorporated in the Cayman Islands, operating in the field of laboratory and bioequivalence studies services. The company collaborates with Hangzhou Tigermed, a controlling shareholder, to provide services such as biometrics, electronic data capture software, and clinical site management organization services.
Average Trading Volume: 529,056
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.09B
See more data about 1521 stock on TipRanks’ Stock Analysis page.